Cytos proposes rights offering

Cytos Biotechnology AG (SIX:CYTN), Zurich, Switzerland Business: Neurology, Inflammation, Cardiovascular Date announced: 3/21/12 Type: Rights offering To be raised: Up to CHF5 million ($5.5 million) S...